{"search_session":{},"preferences":{"l":"en","queryLanguage":"en"},"patentId":"079-589-025-544-452","frontPageModel":{"patentViewModel":{"ref":{"entityRefId":"079-589-025-544-452","entityRefType":"PATENT"},"entityMetadata":{"linkedIds":{"empty":true},"tags":[],"collections":[{"id":184804,"type":"PATENT","title":"cancer metodo","description":"metodo cancer","access":"OPEN_ACCESS","displayAvatar":true,"attested":false,"itemCount":50000,"tags":[],"user":{"id":371336820,"username":"brevelo","firstName":"","lastName":"","created":"2020-09-30T00:10:43.000Z","displayName":"brevelo","accountType":"PERSONAL","isOauthOnly":false},"notes":[],"sharedType":"PUBLISHED","hasLinkedSavedQueries":false,"savedQueries":[],"created":"2020-10-28T00:54:30Z","updated":"2020-10-28T00:56:49Z","lastEventDate":"2020-10-28T00:56:49Z"},{"id":191941,"type":"PATENT","title":"membrane receptor AND Cancer Cell","description":"","access":"OPEN_ACCESS","displayAvatar":false,"attested":false,"itemCount":50000,"tags":[],"user":{"id":390700588,"username":"diegot","firstName":"Diego","lastName":"Triviño Bolaños","created":"2021-02-12T02:57:12.000Z","displayName":"Diego Triviño Bolaños","profilePictureKey":"lens/avatar/92b0de89-d77f-4973-b88a-4a0e06ac93e4","avatar":{"id":977,"key":"lens/avatar/92b0de89-d77f-4973-b88a-4a0e06ac93e4"},"preferences":"{}","accountType":"PERSONAL","isOauthOnly":false},"notes":[],"sharedType":"PUBLISHED","hasLinkedSavedQueries":true,"savedQueries":[],"created":"2021-06-10T15:02:07Z","updated":"2021-06-10T15:02:11Z","lastEventDate":"2021-06-10T15:02:11Z"},{"id":192217,"type":"PATENT","title":"FC-DAFC","description":"","access":"OPEN_ACCESS","displayAvatar":false,"attested":false,"itemCount":50000,"tags":[],"user":{"id":396678780,"username":"diego1983","firstName":"","lastName":"","created":"2021-03-23T21:51:31.000Z","displayName":"diego1983","preferences":"{\"usage\":\"public\"}","accountType":"PERSONAL","isOauthOnly":false},"notes":[],"sharedType":"PUBLISHED","hasLinkedSavedQueries":true,"savedQueries":[],"created":"2021-06-20T13:09:25Z","updated":"2021-06-20T13:09:30Z","lastEventDate":"2021-06-20T13:09:30Z"},{"id":192219,"type":"PATENT","title":"FC-PEMFC","description":"","access":"OPEN_ACCESS","displayAvatar":false,"attested":false,"itemCount":50000,"tags":[],"user":{"id":396678780,"username":"diego1983","firstName":"","lastName":"","created":"2021-03-23T21:51:31.000Z","displayName":"diego1983","preferences":"{\"usage\":\"public\"}","accountType":"PERSONAL","isOauthOnly":false},"notes":[],"sharedType":"PUBLISHED","hasLinkedSavedQueries":true,"savedQueries":[],"created":"2021-06-20T13:12:48Z","updated":"2022-11-15T16:34:12Z","lastEventDate":"2022-11-15T16:34:12Z"},{"id":192221,"type":"PATENT","title":"FC-DAFC-PEMFC","description":"","access":"OPEN_ACCESS","displayAvatar":false,"attested":false,"itemCount":19100,"tags":[],"user":{"id":396678780,"username":"diego1983","firstName":"","lastName":"","created":"2021-03-23T21:51:31.000Z","displayName":"diego1983","preferences":"{\"usage\":\"public\"}","accountType":"PERSONAL","isOauthOnly":false},"notes":[],"sharedType":"PUBLISHED","hasLinkedSavedQueries":true,"savedQueries":[],"created":"2021-06-20T13:15:48Z","updated":"2024-03-28T01:50:46Z","lastEventDate":"2024-03-28T01:50:46Z"},{"id":203485,"type":"PATENT","title":"20180102之后的cas专利","description":"","access":"OPEN_ACCESS","displayAvatar":true,"attested":false,"itemCount":47014,"tags":[],"user":{"id":467477814,"username":"zhoulevi","firstName":"levi","lastName":"zhou","created":"2022-08-24T06:34:04.000Z","displayName":"Levi Zhou","preferences":"{}","accountType":"PERSONAL","isOauthOnly":false},"notes":[],"sharedType":"PUBLISHED","hasLinkedSavedQueries":true,"savedQueries":[],"created":"2022-08-24T08:37:30Z","updated":"2023-11-16T00:15:50Z","lastEventDate":"2023-11-16T00:15:50Z"},{"id":213550,"type":"PATENT","title":"20191004","description":"","access":"OPEN_ACCESS","displayAvatar":true,"attested":false,"itemCount":48337,"tags":[],"user":{"id":535764679,"username":"jackgreen12345","firstName":"","lastName":"","created":"2023-10-11T07:57:16.000Z","displayName":"jackgreen12345","preferences":"{}","accountType":"PERSONAL","isOauthOnly":false},"notes":[],"sharedType":"PUBLISHED","hasLinkedSavedQueries":false,"savedQueries":[],"created":"2023-10-11T10:37:59Z","updated":"2023-10-11T10:38:03Z","lastEventDate":"2023-10-11T10:38:03Z"},{"id":214668,"type":"PATENT","title":"FRGS 2024 Application","description":"","access":"OPEN_ACCESS","displayAvatar":true,"attested":false,"itemCount":1535,"tags":[],"user":{"id":546153941,"username":"mazlinda","firstName":"","lastName":"","created":"2023-11-17T05:16:59.000Z","displayName":"mazlinda","accountType":"PERSONAL","isOauthOnly":false},"notes":[],"sharedType":"PUBLISHED","hasLinkedSavedQueries":true,"savedQueries":[],"created":"2023-11-17T05:38:28Z","updated":"2024-03-28T01:54:29Z","lastEventDate":"2024-03-28T01:54:29Z"},{"id":215576,"type":"PATENT","title":"US_Granted_Active_A61P","description":"","access":"OPEN_ACCESS","displayAvatar":true,"attested":false,"itemCount":50000,"tags":[],"user":{"id":416214387,"username":"pi3kakt","firstName":"Yu Ren","lastName":"Wang","created":"2021-08-15T09:18:15.000Z","displayName":"Yu Ren Wang","preferences":"{\"usage\":\"public\"}","accountType":"PERSONAL","isOauthOnly":false},"notes":[],"sharedType":"PUBLISHED","hasLinkedSavedQueries":false,"savedQueries":[],"created":"2023-12-12T09:26:41Z","updated":"2023-12-12T09:26:44Z","lastEventDate":"2023-12-12T09:26:44Z"},{"id":217480,"type":"PATENT","title":"Anesthesia Technology","description":"","access":"OPEN_ACCESS","displayAvatar":true,"attested":false,"itemCount":50000,"tags":[],"user":{"id":565770388,"username":"Medicine ","firstName":"Wally","lastName":"Elijah","created":"2024-02-11T09:32:19.000Z","displayName":"Wally Elijah","accountType":"PERSONAL","isOauthOnly":true},"notes":[],"sharedType":"PUBLISHED","hasLinkedSavedQueries":true,"savedQueries":[],"created":"2024-02-11T09:43:30Z","updated":"2024-02-11T09:43:33Z","lastEventDate":"2024-02-11T09:43:33Z"}],"notes":[],"inventorships":[],"privateCollections":[],"publicCollections":[{"id":184804,"type":"PATENT","title":"cancer metodo","description":"metodo cancer","access":"OPEN_ACCESS","displayAvatar":true,"attested":false,"itemCount":50000,"tags":[],"user":{"id":371336820,"username":"brevelo","firstName":"","lastName":"","created":"2020-09-30T00:10:43.000Z","displayName":"brevelo","accountType":"PERSONAL","isOauthOnly":false},"notes":[],"sharedType":"PUBLISHED","hasLinkedSavedQueries":false,"savedQueries":[],"created":"2020-10-28T00:54:30Z","updated":"2020-10-28T00:56:49Z","lastEventDate":"2020-10-28T00:56:49Z"},{"id":191941,"type":"PATENT","title":"membrane receptor AND Cancer Cell","description":"","access":"OPEN_ACCESS","displayAvatar":false,"attested":false,"itemCount":50000,"tags":[],"user":{"id":390700588,"username":"diegot","firstName":"Diego","lastName":"Triviño Bolaños","created":"2021-02-12T02:57:12.000Z","displayName":"Diego Triviño Bolaños","profilePictureKey":"lens/avatar/92b0de89-d77f-4973-b88a-4a0e06ac93e4","avatar":{"id":977,"key":"lens/avatar/92b0de89-d77f-4973-b88a-4a0e06ac93e4"},"preferences":"{}","accountType":"PERSONAL","isOauthOnly":false},"notes":[],"sharedType":"PUBLISHED","hasLinkedSavedQueries":true,"savedQueries":[],"created":"2021-06-10T15:02:07Z","updated":"2021-06-10T15:02:11Z","lastEventDate":"2021-06-10T15:02:11Z"},{"id":192217,"type":"PATENT","title":"FC-DAFC","description":"","access":"OPEN_ACCESS","displayAvatar":false,"attested":false,"itemCount":50000,"tags":[],"user":{"id":396678780,"username":"diego1983","firstName":"","lastName":"","created":"2021-03-23T21:51:31.000Z","displayName":"diego1983","preferences":"{\"usage\":\"public\"}","accountType":"PERSONAL","isOauthOnly":false},"notes":[],"sharedType":"PUBLISHED","hasLinkedSavedQueries":true,"savedQueries":[],"created":"2021-06-20T13:09:25Z","updated":"2021-06-20T13:09:30Z","lastEventDate":"2021-06-20T13:09:30Z"},{"id":192219,"type":"PATENT","title":"FC-PEMFC","description":"","access":"OPEN_ACCESS","displayAvatar":false,"attested":false,"itemCount":50000,"tags":[],"user":{"id":396678780,"username":"diego1983","firstName":"","lastName":"","created":"2021-03-23T21:51:31.000Z","displayName":"diego1983","preferences":"{\"usage\":\"public\"}","accountType":"PERSONAL","isOauthOnly":false},"notes":[],"sharedType":"PUBLISHED","hasLinkedSavedQueries":true,"savedQueries":[],"created":"2021-06-20T13:12:48Z","updated":"2022-11-15T16:34:12Z","lastEventDate":"2022-11-15T16:34:12Z"},{"id":192221,"type":"PATENT","title":"FC-DAFC-PEMFC","description":"","access":"OPEN_ACCESS","displayAvatar":false,"attested":false,"itemCount":19100,"tags":[],"user":{"id":396678780,"username":"diego1983","firstName":"","lastName":"","created":"2021-03-23T21:51:31.000Z","displayName":"diego1983","preferences":"{\"usage\":\"public\"}","accountType":"PERSONAL","isOauthOnly":false},"notes":[],"sharedType":"PUBLISHED","hasLinkedSavedQueries":true,"savedQueries":[],"created":"2021-06-20T13:15:48Z","updated":"2024-03-28T01:50:46Z","lastEventDate":"2024-03-28T01:50:46Z"},{"id":203485,"type":"PATENT","title":"20180102之后的cas专利","description":"","access":"OPEN_ACCESS","displayAvatar":true,"attested":false,"itemCount":47014,"tags":[],"user":{"id":467477814,"username":"zhoulevi","firstName":"levi","lastName":"zhou","created":"2022-08-24T06:34:04.000Z","displayName":"Levi Zhou","preferences":"{}","accountType":"PERSONAL","isOauthOnly":false},"notes":[],"sharedType":"PUBLISHED","hasLinkedSavedQueries":true,"savedQueries":[],"created":"2022-08-24T08:37:30Z","updated":"2023-11-16T00:15:50Z","lastEventDate":"2023-11-16T00:15:50Z"},{"id":213550,"type":"PATENT","title":"20191004","description":"","access":"OPEN_ACCESS","displayAvatar":true,"attested":false,"itemCount":48337,"tags":[],"user":{"id":535764679,"username":"jackgreen12345","firstName":"","lastName":"","created":"2023-10-11T07:57:16.000Z","displayName":"jackgreen12345","preferences":"{}","accountType":"PERSONAL","isOauthOnly":false},"notes":[],"sharedType":"PUBLISHED","hasLinkedSavedQueries":false,"savedQueries":[],"created":"2023-10-11T10:37:59Z","updated":"2023-10-11T10:38:03Z","lastEventDate":"2023-10-11T10:38:03Z"},{"id":214668,"type":"PATENT","title":"FRGS 2024 Application","description":"","access":"OPEN_ACCESS","displayAvatar":true,"attested":false,"itemCount":1535,"tags":[],"user":{"id":546153941,"username":"mazlinda","firstName":"","lastName":"","created":"2023-11-17T05:16:59.000Z","displayName":"mazlinda","accountType":"PERSONAL","isOauthOnly":false},"notes":[],"sharedType":"PUBLISHED","hasLinkedSavedQueries":true,"savedQueries":[],"created":"2023-11-17T05:38:28Z","updated":"2024-03-28T01:54:29Z","lastEventDate":"2024-03-28T01:54:29Z"},{"id":215576,"type":"PATENT","title":"US_Granted_Active_A61P","description":"","access":"OPEN_ACCESS","displayAvatar":true,"attested":false,"itemCount":50000,"tags":[],"user":{"id":416214387,"username":"pi3kakt","firstName":"Yu Ren","lastName":"Wang","created":"2021-08-15T09:18:15.000Z","displayName":"Yu Ren Wang","preferences":"{\"usage\":\"public\"}","accountType":"PERSONAL","isOauthOnly":false},"notes":[],"sharedType":"PUBLISHED","hasLinkedSavedQueries":false,"savedQueries":[],"created":"2023-12-12T09:26:41Z","updated":"2023-12-12T09:26:44Z","lastEventDate":"2023-12-12T09:26:44Z"},{"id":217480,"type":"PATENT","title":"Anesthesia Technology","description":"","access":"OPEN_ACCESS","displayAvatar":true,"attested":false,"itemCount":50000,"tags":[],"user":{"id":565770388,"username":"Medicine ","firstName":"Wally","lastName":"Elijah","created":"2024-02-11T09:32:19.000Z","displayName":"Wally Elijah","accountType":"PERSONAL","isOauthOnly":true},"notes":[],"sharedType":"PUBLISHED","hasLinkedSavedQueries":true,"savedQueries":[],"created":"2024-02-11T09:43:30Z","updated":"2024-02-11T09:43:33Z","lastEventDate":"2024-02-11T09:43:33Z"}],"privateNotes":[],"landscapeCollections":[],"landscapeNotes":[]},"document":{"record_lens_id":"079-589-025-544-452","lens_id":["079-589-025-544-452","003-842-922-795-103"],"doc_key":"US_10450596_B2_20191022","created":"2019-10-31T18:42:02.285","docdb_id":520809436,"lens_internal":{"earliest_lens_id_created_time":"2019-10-31T18:42:02.285","last_modified":"2024-03-25T10:00:16.696","legacy_pub_key":"US_10450596_B2","has_doc_lang":true,"has_biblio_lang":true,"has_all_title_lang":true,"has_all_abstract_lang":true,"has_all_claims_lang":true,"has_description_lang":true},"jurisdiction":"US","doc_number":"10450596","kind":"B2","date_published":"2019-10-22","year_published":2019,"ids":["US_10450596_B2","079-589-025-544-452","003-842-922-795-103","US_10450596_B2_20191022","US","10450596","B2","US10450596B2","US10450596","10450596B2"],"lang":"en","publication_type":"GRANTED_PATENT","application_reference":{"jurisdiction":"US","doc_number":"201515129167","kind":"A","date":"2015-03-27"},"priority_claim":[{"jurisdiction":"US","doc_number":"201515129167","kind":"A","date":"2015-03-27"},{"jurisdiction":"US","doc_number":"201461972091","kind":"P","date":"2014-03-28"},{"jurisdiction":"US","doc_number":"2015023038","kind":"W","date":"2015-03-27"}],"priority_claim.source":"DOCDB","earliest_priority_claim_date":"2014-03-28","title":{"en":[{"text":"L-2-hydroxyglutarate and stress induced metabolism","lang":"en","source":"DOCDB","data_format":"DOCDBA"}]},"title_lang":["en"],"has_title":true,"applicant":[{"name":"MEMORIAL SLOAN KETTERING CANCER CENTER","residence":"US","sequence":1,"app_type":"applicant"}],"applicant_count":1,"has_applicant":true,"inventor":[{"name":"INTLEKOFER ANDREW M","residence":"US","sequence":1},{"name":"THOMPSON CRAIG B","residence":"US","sequence":2}],"inventor_count":2,"has_inventor":true,"agent":[{"name":"Choate, Hall & Stewart LLP","sequence":1},{"name":"Brenda Herschbach Jarrell","sequence":2},{"name":"David E. Shore","sequence":3}],"agent_count":3,"has_agent":true,"owner":[{"name":"MEMORIAL SLOAN-KETTERING CANCER CENTER","address":"1275 YORK AVENUE, NEW YORK, NEW YORK, 10065","sequence":2,"recorded_date":"2016-09-29","execution_date":"2015-05-05","is_current_owner":true}],"owner_count":1,"owner_all":[{"name":"MEMORIAL SLOAN-KETTERING CANCER CENTER","address":"1275 YORK AVENUE, NEW YORK, NEW YORK, 10065","sequence":2,"recorded_date":"2016-09-29","execution_date":"2015-05-05","is_current_owner":true}],"owner_all_count":1,"has_owner":true,"primary_examiner":{"name":"Erin M. Bowers","department":"1653"},"has_examiner":true,"class_ipcr":[{"symbol":"A61K31/711","version_indicator":"2006-01-01","class_symbol_position":"F","class_value":"I","action_date":"2019-10-22","class_status":"B","class_data_source":"H","generating_office":"US","sequence":1},{"symbol":"C12Q1/32","version_indicator":"2006-01-01","class_symbol_position":"L","class_value":"I","action_date":"2019-10-22","class_status":"B","class_data_source":"H","generating_office":"US","sequence":2},{"symbol":"G01N33/50","version_indicator":"2006-01-01","class_symbol_position":"L","class_value":"I","action_date":"2019-10-22","class_status":"B","class_data_source":"H","generating_office":"US","sequence":3}],"class_ipcr.first_symbol":"A61K31/711","class_ipcr.later_symbol":["C12Q1/32","G01N33/50"],"class_ipcr.inv_symbol":["A61K31/711","C12Q1/32","G01N33/50"],"class_ipcr.add_symbol":[],"class_ipcr.source":"DOCDB","class_cpc":[{"symbol":"G01N33/5091","version_indicator":"2013-01-01","class_symbol_position":"L","class_value":"I","action_date":"2017-06-22","class_status":"B","class_data_source":"H","generating_office":"EP","sequence":1},{"symbol":"G01N2500/10","version_indicator":"2013-01-01","class_symbol_position":"L","class_value":"A","action_date":"2016-02-09","class_status":"B","class_data_source":"H","generating_office":"EP","sequence":2},{"symbol":"G01N2800/7038","version_indicator":"2013-01-01","class_symbol_position":"L","class_value":"A","action_date":"2016-02-09","class_status":"B","class_data_source":"H","generating_office":"EP","sequence":3},{"symbol":"A61K31/711","version_indicator":"2013-01-01","class_symbol_position":"L","class_value":"I","action_date":"2019-05-03","class_status":"B","class_data_source":"H","generating_office":"EP","sequence":4},{"symbol":"C12Q1/32","version_indicator":"2013-01-01","class_symbol_position":"F","class_value":"I","action_date":"2017-06-22","class_status":"B","class_data_source":"H","generating_office":"EP","sequence":5},{"symbol":"A61P11/00","version_indicator":"2018-01-01","class_symbol_position":"L","class_value":"I","action_date":"2020-03-18","class_status":"B","class_data_source":"H","generating_office":"EP","sequence":6},{"symbol":"A61P11/06","version_indicator":"2018-01-01","class_symbol_position":"L","class_value":"I","action_date":"2020-03-18","class_status":"B","class_data_source":"H","generating_office":"EP","sequence":7},{"symbol":"A61P31/00","version_indicator":"2018-01-01","class_symbol_position":"L","class_value":"I","action_date":"2020-03-27","class_status":"B","class_data_source":"H","generating_office":"EP","sequence":8},{"symbol":"A61P35/00","version_indicator":"2018-01-01","class_symbol_position":"L","class_value":"I","action_date":"2020-03-27","class_status":"B","class_data_source":"H","generating_office":"EP","sequence":9},{"symbol":"A61P9/00","version_indicator":"2018-01-01","class_symbol_position":"L","class_value":"I","action_date":"2020-03-31","class_status":"B","class_data_source":"H","generating_office":"EP","sequence":10},{"symbol":"A61P9/10","version_indicator":"2018-01-01","class_symbol_position":"L","class_value":"I","action_date":"2020-03-31","class_status":"B","class_data_source":"H","generating_office":"EP","sequence":11},{"symbol":"A61K31/711","version_indicator":"2013-01-01","class_symbol_position":"L","class_value":"I","action_date":"2019-05-03","class_status":"B","class_data_source":"H","generating_office":"US","sequence":12},{"symbol":"G01N33/5091","version_indicator":"2013-01-01","class_symbol_position":"L","class_value":"I","action_date":"2017-06-22","class_status":"B","class_data_source":"H","generating_office":"US","sequence":13},{"symbol":"G01N2500/10","version_indicator":"2013-01-01","class_symbol_position":"L","class_value":"A","action_date":"2016-02-09","class_status":"B","class_data_source":"H","generating_office":"US","sequence":14},{"symbol":"G01N2800/7038","version_indicator":"2013-01-01","class_symbol_position":"L","class_value":"A","action_date":"2016-02-09","class_status":"B","class_data_source":"H","generating_office":"US","sequence":15},{"symbol":"C12Q1/32","version_indicator":"2013-01-01","class_symbol_position":"F","class_value":"I","action_date":"2017-06-22","class_status":"B","class_data_source":"H","generating_office":"US","sequence":16}],"class_cpc_cset":[],"class_cpc.first_symbol":"C12Q1/32","class_cpc.later_symbol":["G01N33/5091","G01N2500/10","G01N2800/7038","A61K31/711","A61P11/00","A61P11/06","A61P31/00","A61P35/00","A61P9/00","A61P9/10","A61K31/711","G01N33/5091","G01N2500/10","G01N2800/7038"],"class_cpc.inv_symbol":["G01N33/5091","A61K31/711","C12Q1/32","A61P11/00","A61P11/06","A61P31/00","A61P35/00","A61P9/00","A61P9/10","A61K31/711","G01N33/5091","C12Q1/32"],"class_cpc.add_symbol":["G01N2500/10","G01N2800/7038","G01N2500/10","G01N2800/7038"],"class_cpc.source":"DOCDB","class_national":[],"class_national.later_symbol":[],"reference_cited":[{"patent":{"num":1,"document_id":{"jurisdiction":"US","doc_number":"2002192737","kind":"A1","date":"2002-12-19","name":"KAELIN WILLIAM G [US], et al"},"lens_id":"114-029-379-508-91X","category":[],"us_category":[],"cited_phase":"APP","rel_claims":[],"sequence":1}},{"patent":{"num":2,"document_id":{"jurisdiction":"US","doc_number":"2006084123","kind":"A1","date":"2006-04-20","name":"HARRIS ADRIAN L [GB], et al"},"lens_id":"179-467-988-108-231","category":[],"us_category":[],"cited_phase":"APP","rel_claims":[],"sequence":2}},{"patent":{"num":3,"document_id":{"jurisdiction":"US","doc_number":"2012202883","kind":"A1","date":"2012-08-09","name":"HAI YAN [US], et al"},"lens_id":"190-092-332-123-404","category":[],"us_category":[],"cited_phase":"APP","rel_claims":[],"sequence":3}},{"patent":{"num":4,"document_id":{"jurisdiction":"US","doc_number":"2013109643","kind":"A1","date":"2013-05-02","name":"RIGGINS GREGORY JOSEPH [US], et al"},"lens_id":"091-166-609-223-898","category":[],"us_category":[],"cited_phase":"APP","rel_claims":[],"sequence":4}},{"patent":{"num":5,"document_id":{"jurisdiction":"US","doc_number":"2013316385","kind":"A1","date":"2013-11-28","name":"CANTLEY LEWIS C [US], et al"},"lens_id":"016-384-169-609-599","category":[],"us_category":[],"cited_phase":"APP","rel_claims":[],"sequence":5}},{"patent":{"num":6,"document_id":{"jurisdiction":"US","doc_number":"2014067234","kind":"A1","date":"2014-03-06","name":"BROWN CORY ANDREW [US]"},"lens_id":"005-036-376-555-837","category":[],"us_category":[],"cited_phase":"APP","rel_claims":[],"sequence":6}},{"patent":{"num":7,"document_id":{"jurisdiction":"US","doc_number":"2014314728","kind":"A1","date":"2014-10-23","name":"WISE DAVID R [US], et al"},"lens_id":"161-296-125-417-226","category":[],"us_category":[],"cited_phase":"APP","rel_claims":[],"sequence":7}},{"patent":{"num":8,"document_id":{"jurisdiction":"WO","doc_number":"2004046729","kind":"A2","date":"2004-06-03","name":"UNIV LEICESTER [GB], et al"},"lens_id":"121-949-476-091-285","category":[],"us_category":[],"cited_phase":"APP","rel_claims":[],"sequence":8}},{"patent":{"num":9,"document_id":{"jurisdiction":"WO","doc_number":"2010105243","kind":"A1","date":"2010-09-16","name":"AGIOS PHARMACEUTICALS INC [US], et al"},"lens_id":"188-085-864-017-162","category":[],"us_category":[],"cited_phase":"APP","rel_claims":[],"sequence":9}},{"patent":{"num":10,"document_id":{"jurisdiction":"WO","doc_number":"2011050211","kind":"A2","date":"2011-04-28","name":"AGIOS PHARMACEUTICALS INC [US], et al"},"lens_id":"032-760-974-269-554","category":[],"us_category":[],"cited_phase":"APP","rel_claims":[],"sequence":10}},{"patent":{"num":11,"document_id":{"jurisdiction":"WO","doc_number":"2011143160","kind":"A2","date":"2011-11-17","name":"UNIV JOHNS HOPKINS [US], et al"},"lens_id":"145-571-565-922-000","category":[],"us_category":[],"cited_phase":"APP","rel_claims":[],"sequence":11}},{"patent":{"num":12,"document_id":{"jurisdiction":"WO","doc_number":"2013075065","kind":"A1","date":"2013-05-23","name":"SLOAN KETTERING INST CANCER [US]"},"lens_id":"047-408-943-905-441","category":[],"us_category":[],"cited_phase":"APP","rel_claims":[],"sequence":12}},{"npl":{"num":1,"text":"Achouri, Y. et al., Identification of a dehydrogenase acting on D-2-hydroxyglutarate, The Biochemical Journal 381, 35-42 (2004).","npl_type":"a","external_id":["10.1042/bj20031933","15070399","pmc1133759"],"record_lens_id":"020-265-819-581-798","lens_id":["117-174-961-521-589","020-265-819-581-798","117-552-127-649-746"],"sequence":13,"category":[],"us_category":[],"cited_phase":"APP","rel_claims":[]}},{"npl":{"num":2,"text":"Albers, E., et al., Distribution of 14C-labelled carbon from glucose and glutamate during anaerobic growth of Saccharomyces cerevisiae, Microbiology 144 ( Pt 6), 1683-1690 (1998).","npl_type":"a","external_id":["10.1099/00221287-144-6-1683","9639938"],"record_lens_id":"036-599-455-638-642","lens_id":["157-273-842-850-210","036-599-455-638-642","182-870-895-920-288"],"sequence":14,"category":[],"us_category":[],"cited_phase":"APP","rel_claims":[]}},{"npl":{"num":3,"text":"Amary, M.F., et al., IDH1 and IDH2 mutations are frequent events in central chondrosarcoma and central and periosteal chondromas but not in other mesenchymal tumours, The Journal of Pathology 224, 334-343 (2011).","npl_type":"a","external_id":["21598255","10.1002/path.2913"],"record_lens_id":"004-567-920-743-687","lens_id":["164-187-728-576-29X","121-950-089-888-284","004-567-920-743-687"],"sequence":15,"category":[],"us_category":[],"cited_phase":"APP","rel_claims":[]}},{"npl":{"num":4,"text":"Author Not Known, Definition of Chronic Hypoxia, Mosby's Dictionary of Medicine, Nursing, and Health Professions, 9th Edition (Print), p. 363 (2012).","npl_type":"a","external_id":[],"lens_id":[],"sequence":16,"category":[],"us_category":[],"cited_phase":"APP","rel_claims":[]}},{"npl":{"num":5,"text":"Banks, J.L., et al., Integrated Modeling Program, Applied Chemical Theory (IMPACT), Journal of Computational Chemistry 26, 1752-1780 (2005).","npl_type":"a","external_id":["10.1002/jcc.20292","16211539","pmc2742605"],"record_lens_id":"040-058-870-915-427","lens_id":["136-036-694-859-465","040-058-870-915-427","168-718-245-583-749"],"sequence":17,"category":[],"us_category":[],"cited_phase":"APP","rel_claims":[]}},{"npl":{"num":6,"text":"Bensaad, K., and Harris, A.L., Hypoxia and metabolism in cancer, Advances in Experimental Medicine and Biology 772, 1-39 (2014).","npl_type":"a","external_id":["24272352","10.1007/978-1-4614-5915-6_1"],"record_lens_id":"029-780-582-205-180","lens_id":["039-844-903-689-722","190-283-288-931-448","029-780-582-205-180"],"sequence":18,"category":[],"us_category":[],"cited_phase":"APP","rel_claims":[]}},{"npl":{"num":7,"text":"Borger, D.R., et al., Frequent mutation of isocitrate dehydrogenase (IDH)1 and IDH2 in cholangiocarcinoma identified through broad-based tumor genotyping, The Oncologist 17, 72-79 (2012).","npl_type":"a","external_id":["22180306","pmc3267826","10.1634/theoncologist.2011-0386"],"record_lens_id":"059-903-055-863-582","lens_id":["092-779-283-471-899","147-227-408-020-652","059-903-055-863-582"],"sequence":19,"category":[],"us_category":[],"cited_phase":"APP","rel_claims":[]}},{"npl":{"num":8,"text":"Brown, J. M., Chapter 15: Tumor Hypoxia in Cancer Therapy, Methods in Enzymology, Section 4: Hypoxia and Tumor Biology, 35:295-321 (2007).","npl_type":"a","external_id":["17998060","10.1016/s0076-6879(07)35015-5"],"record_lens_id":"082-220-974-229-225","lens_id":["166-613-508-408-042","082-394-800-170-024","082-220-974-229-225"],"sequence":20,"category":[],"us_category":[],"cited_phase":"APP","rel_claims":[]}},{"npl":{"num":9,"text":"Cairns, R.A., et al., IDH2 mutations are frequent in angioimmunoblastic T-cell lymphoma, Blood, 119:1901-1903 (2012).","npl_type":"a","external_id":["10.1182/blood-2011-11-391748","pmc3293643","22215888"],"record_lens_id":"109-103-540-292-097","lens_id":["114-461-135-725-945","155-858-469-226-831","109-103-540-292-097"],"sequence":21,"category":[],"us_category":[],"cited_phase":"APP","rel_claims":[]}},{"npl":{"num":10,"text":"Chang, C. M. et al., The Role of Isocitrate Dehydrogenase Mutations in Glioma Brain Tumors, Molecular Targets of CNS Tumors, pp. 413-436 (2011).","npl_type":"a","external_id":["10.5772/23238"],"record_lens_id":"075-400-325-609-206","lens_id":["160-771-645-956-825","075-400-325-609-206"],"sequence":22,"category":[],"us_category":[],"cited_phase":"APP","rel_claims":[]}},{"npl":{"num":11,"text":"Chen, C., et al., Cancer-associated IDH2 mutants drive an acute myeloid leukemia that is susceptible to Brd4 inhibition, Genes & Development, 27:1974-1985 (2013).","npl_type":"a","external_id":["10.1101/gad.226613.113","24065765","pmc3792474"],"record_lens_id":"003-245-364-414-98X","lens_id":["031-131-557-137-384","003-245-364-414-98X","141-902-384-316-966"],"sequence":23,"category":[],"us_category":[],"cited_phase":"APP","rel_claims":[]}},{"npl":{"num":12,"text":"Chowdhury, R., et al., The oncometabolite 2-hydroxyglutarate inhibits histone lysine demethylases, EMBO Reports, 12:463-469 (2011).","npl_type":"a","external_id":["21460794","10.1038/embor.2011.43","pmc3090014"],"record_lens_id":"031-916-964-982-622","lens_id":["160-370-431-466-866","116-400-196-247-856","031-916-964-982-622"],"sequence":24,"category":[],"us_category":[],"cited_phase":"APP","rel_claims":[]}},{"npl":{"num":13,"text":"Dang, L.et al., Cancer-associated IDH1 mutations produce 2-hydroxyglutarate, Nature, 462(7274):739-44 (2009).","npl_type":"a","external_id":["19935646","10.1038/nature08617","pmc2818760"],"record_lens_id":"051-346-123-101-804","lens_id":["052-848-905-020-36X","130-523-432-781-637","051-346-123-101-804"],"sequence":25,"category":[],"us_category":[],"cited_phase":"APP","rel_claims":[]}},{"npl":{"num":14,"text":"Deberardinis, R.J. et al., Beyond aerobic glycolysis: transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis, Proc. Natl. Acad. Sci. USA, 104(49):19345-50 (2007).","npl_type":"a","external_id":["18032601","pmc2148292","10.1073/pnas.0709747104"],"record_lens_id":"073-039-032-761-661","lens_id":["085-740-214-847-731","137-204-522-159-08X","073-039-032-761-661"],"sequence":26,"category":[],"us_category":[],"cited_phase":"APP","rel_claims":[]}},{"npl":{"num":15,"text":"Duan, J.X. et al., Potent and highly selective hypoxia-activated achiral phosphoramidate mustards as anticancer drugs, J. Med. Chem., 51(8):2412-20 (2008).","npl_type":"a","external_id":["18257544","10.1021/jm701028q"],"record_lens_id":"000-042-858-398-204","lens_id":["151-386-928-223-464","146-886-089-606-105","000-042-858-398-204"],"sequence":27,"category":[],"us_category":[],"cited_phase":"APP","rel_claims":[]}},{"npl":{"num":16,"text":"Extended European Search Report for EP 12850119.4, 12 pages (dated Sep. 2, 2015).","npl_type":"a","external_id":[],"lens_id":[],"sequence":28,"category":[],"us_category":[],"cited_phase":"APP","rel_claims":[]}},{"npl":{"num":17,"text":"Figueroa, M.E., et al., Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation, Cancer Cell, 18:553-567 (2010).","npl_type":"a","external_id":["pmc4105845","10.1016/j.ccr.2010.11.015","10.3410/f.6799956.6969054","21130701"],"record_lens_id":"065-629-939-575-218","lens_id":["086-687-121-061-859","139-305-220-666-196","173-163-799-927-130","065-629-939-575-218","136-987-928-657-457"],"sequence":29,"category":[],"us_category":[],"cited_phase":"APP","rel_claims":[]}},{"npl":{"num":18,"text":"Friesner, R.A., et al., Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes, Journal of Medicinal Chemistry, 49:6177-6196 (2006).","npl_type":"a","external_id":["10.1021/jm051256o","10.1021/jm051256o.s001","17034125"],"record_lens_id":"107-500-141-832-929","lens_id":["129-862-464-788-543","107-500-141-832-929","167-752-044-583-147","170-565-147-651-039"],"sequence":30,"category":[],"us_category":[],"cited_phase":"APP","rel_claims":[]}},{"npl":{"num":19,"text":"Friesner, R.A., et al., Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy, Journal of Medicinal Chemistry, 47:1739-1749 (2004).","npl_type":"a","external_id":["15027865","10.1021/jm0306430"],"record_lens_id":"012-837-906-825-915","lens_id":["026-371-078-068-862","012-837-906-825-915","194-687-376-542-270"],"sequence":31,"category":[],"us_category":[],"cited_phase":"APP","rel_claims":[]}},{"npl":{"num":20,"text":"Gross, S., et al., Cancer-associated metabolite 2-hydroxyglutarate accumulates in acute myelogenous leukemia with isocitrate dehydrogenase 1 and 2 mutations, The Journal of Experimental Medicine, 207:339-344 (2010).","npl_type":"a","external_id":["20142433","10.1084/jem.20092506","pmc2822606"],"record_lens_id":"020-965-515-661-331","lens_id":["130-452-841-142-478","158-414-406-281-704","020-965-515-661-331"],"sequence":32,"category":[],"us_category":[],"cited_phase":"APP","rel_claims":[]}},{"npl":{"num":21,"text":"Halgren, T.A., et al., Glide: a new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening, Journal of Medicinal Chemistry, 47:1750-1759 (2004).","npl_type":"a","external_id":["15027866","10.1021/jm030644s"],"record_lens_id":"015-002-496-264-505","lens_id":["117-447-637-218-60X","015-002-496-264-505","167-956-549-717-432"],"sequence":33,"category":[],"us_category":[],"cited_phase":"APP","rel_claims":[]}},{"npl":{"num":22,"text":"Haliloglu, G., et al., L-2-hydroxyglutaric aciduria and brain tumors in children with mutations in the L2HGDH gene: neuroimaging findings, Neuropediatrics, 39:119-122 (2008).","npl_type":"a","external_id":["18671189","10.1055/s-2008-1081217"],"record_lens_id":"138-390-758-447-801","lens_id":["179-269-685-686-993","188-366-659-622-823","138-390-758-447-801"],"sequence":34,"category":[],"us_category":[],"cited_phase":"APP","rel_claims":[]}},{"npl":{"num":23,"text":"Hu, C.J., et al., Differential roles of hypoxia-inducible factor 1alpha (HIF-1alpha) and HIF-2alpha in hypoxic gene regulation, Molecular and Cellular Biology, 23:9361-9374 (2003).","npl_type":"a","external_id":["pmc309606","14645546","10.1128/mcb.23.24.9361-9374.2003"],"record_lens_id":"026-154-753-995-782","lens_id":["157-725-626-533-442","026-154-753-995-782","185-460-703-005-26X"],"sequence":35,"category":[],"us_category":[],"cited_phase":"APP","rel_claims":[]}},{"npl":{"num":24,"text":"International Search Report for PCT/US2012/065731, 2 pages (dated Feb. 8, 2013).","npl_type":"a","external_id":[],"lens_id":[],"sequence":36,"category":[],"us_category":[],"cited_phase":"APP","rel_claims":[]}},{"npl":{"num":25,"text":"International Search Report for PCT/US2015/23038, 5 pages (dated Aug. 19, 2015).","npl_type":"a","external_id":[],"lens_id":[],"sequence":37,"category":[],"us_category":[],"cited_phase":"APP","rel_claims":[]}},{"npl":{"num":26,"text":"Jacobson, M.P., et al., A hierarchical approach to all-atom protein loop prediction, Proteins, 55:351-367 (2004).","npl_type":"a","external_id":["15048827","10.1002/prot.10613"],"record_lens_id":"105-796-407-259-262","lens_id":["171-868-952-327-324","105-796-407-259-262","179-519-516-074-442"],"sequence":38,"category":[],"us_category":[],"cited_phase":"APP","rel_claims":[]}},{"npl":{"num":27,"text":"Jacobson, M.P., et al., On the role of the crystal environment in determining protein side-chain conformations, Journal of Molecular Biology, 320:597-608 (2002).","npl_type":"a","external_id":["10.1016/s0022-2836(02)00470-9","12096912"],"record_lens_id":"042-122-685-548-000","lens_id":["084-681-899-048-508","042-122-685-548-000","067-528-995-061-879"],"sequence":39,"category":[],"us_category":[],"cited_phase":"APP","rel_claims":[]}},{"npl":{"num":28,"text":"Kaelin, W.G., Jr., and McKnight, S.L., Influence of metabolism on epigenetics and disease, Cell, 153:56-69 (2013).","npl_type":"a","external_id":["10.1016/j.cell.2013.03.004","23540690","pmc3775362"],"record_lens_id":"056-876-425-247-032","lens_id":["152-996-495-590-983","135-276-901-100-280","056-876-425-247-032"],"sequence":40,"category":[],"us_category":[],"cited_phase":"APP","rel_claims":[]}},{"npl":{"num":29,"text":"Kaelin, W.G., Jr., and Ratcliffe, P.J., Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway, Molecular Cell, 30:393-402 (2008).","npl_type":"a","external_id":["18498744","10.1016/j.molcel.2008.04.009"],"record_lens_id":"090-894-680-848-355","lens_id":["105-092-993-018-115","192-364-700-393-555","090-894-680-848-355"],"sequence":41,"category":[],"us_category":[],"cited_phase":"APP","rel_claims":[]}},{"npl":{"num":30,"text":"Kats, L.M., et al., Proto-oncogenic role of mutant IDH2 in leukemia initiation and maintenance, Cell Stem Cell, 14:329-341 (2014).","npl_type":"a","external_id":["24440599","10.1016/j.stem.2013.12.016","pmc4380188"],"record_lens_id":"020-480-223-222-93X","lens_id":["178-254-454-029-250","020-480-223-222-93X","141-085-629-426-841"],"sequence":42,"category":[],"us_category":[],"cited_phase":"APP","rel_claims":[]}},{"npl":{"num":31,"text":"Kim, J.W. et al., HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia, Cell Metab., 3(3):177-85 (2006).","npl_type":"a","external_id":["16517405","10.1016/j.cmet.2006.02.002"],"record_lens_id":"009-444-782-322-842","lens_id":["134-441-797-299-743","009-444-782-322-842","104-981-910-235-055"],"sequence":43,"category":[],"us_category":[],"cited_phase":"APP","rel_claims":[]}},{"npl":{"num":32,"text":"Koivunen, P., et al., Transformation by the (R)-enantiomer of 2-hydroxyglutarate linked to EGLN activation, Nature, 483:484-488 (2012).","npl_type":"a","external_id":["pmc3656605","22343896","10.1038/nature10898"],"record_lens_id":"031-728-820-954-704","lens_id":["163-008-696-627-503","036-078-237-524-731","031-728-820-954-704"],"sequence":44,"category":[],"us_category":[],"cited_phase":"APP","rel_claims":[]}},{"npl":{"num":33,"text":"Kooistra, S.M., and Helin, K., Molecular mechanisms and potential functions of histone demethylases. Nature Reviews Molecular Cell Biology, 13:297-311 (2012).","npl_type":"a","external_id":["22495436","10.1038/nrm3327","10.1038/nrg3219","22473470"],"record_lens_id":"016-114-066-835-577","lens_id":["032-434-162-343-778","164-094-294-824-774","142-215-969-750-09X","129-726-998-999-63X","016-114-066-835-577","068-878-531-849-189"],"sequence":45,"category":[],"us_category":[],"cited_phase":"APP","rel_claims":[]}},{"npl":{"num":34,"text":"Kranendijk, M., et al., Progress in understanding 2-hydroxyglutaric acidurias, Journal of Inherited Metabolic Disease, 35(4):571-587 (2012).","npl_type":"a","external_id":["pmc3388262","22391998","10.1007/s10545-012-9462-5"],"record_lens_id":"070-302-479-396-687","lens_id":["147-192-995-033-062","161-686-575-391-610","070-302-479-396-687"],"sequence":46,"category":[],"us_category":[],"cited_phase":"APP","rel_claims":[]}},{"npl":{"num":35,"text":"Ley, T.J., et al., DNA sequencing of a cytogenetically normal acute myeloid leukaemia genome, Nature, 456:66-72 (2008).","npl_type":"a","external_id":["18987736","10.1038/nature07485","pmc2603574"],"record_lens_id":"089-592-031-511-745","lens_id":["199-681-899-774-518","174-581-783-929-893","089-592-031-511-745"],"sequence":47,"category":[],"us_category":[],"cited_phase":"APP","rel_claims":[]}},{"npl":{"num":36,"text":"Linster, C.L., et al., Metabolite damage and its repair or pre-emption, Nature Chemical Biology, 9:72-80 (2013).","npl_type":"a","external_id":["10.1038/nchembio.1141","23334546"],"record_lens_id":"057-012-490-658-303","lens_id":["170-489-052-799-792","084-682-337-837-120","057-012-490-658-303"],"sequence":48,"category":[],"us_category":[],"cited_phase":"APP","rel_claims":[]}},{"npl":{"num":37,"text":"Losman, J.A., and Kaelin, W.G., Jr., What a difference a hydroxyl makes: mutant IDH, (R)-2-hydroxyglutarate, and cancer, Genes & Development, 27:836-852 (2013).","npl_type":"a","external_id":["10.1101/gad.217406.113","pmc3650222","23630074"],"record_lens_id":"067-298-737-001-338","lens_id":["114-241-475-715-087","082-366-140-006-166","067-298-737-001-338"],"sequence":49,"category":[],"us_category":[],"cited_phase":"APP","rel_claims":[]}},{"npl":{"num":38,"text":"Losman, J.A., et al., (R)-2-hydroxyglutarate is sufficient to promote leukemogenesis and its effects are reversible, Science, 339:1621-1625 (2013).","npl_type":"a","external_id":["23393090","10.1126/science.1231677","pmc3836459"],"record_lens_id":"015-686-947-939-12X","lens_id":["173-920-693-243-246","092-384-130-532-877","015-686-947-939-12X"],"sequence":50,"category":[],"us_category":[],"cited_phase":"APP","rel_claims":[]}},{"npl":{"num":39,"text":"Lu, C., et al., IDH mutation impairs histone demethylation and results in a block to cell differentiation, Nature, 483:474-478 (2012).","npl_type":"a","external_id":["22343901","10.1038/nature10860","pmc3478770"],"record_lens_id":"057-560-653-321-922","lens_id":["065-569-635-631-442","090-940-795-151-309","057-560-653-321-922"],"sequence":51,"category":[],"us_category":[],"cited_phase":"APP","rel_claims":[]}},{"npl":{"num":40,"text":"Lum, J.J. et al., The transcription factor HIF-1alpha plays a critical role in the growth factor-dependent regulation of both aerobic and anaerobic glycolysis, Genes Dev., 21(9):1037-49 (2007).","npl_type":"a","external_id":["10.1101/gad.1529107","pmc1855230","17437992"],"record_lens_id":"008-118-188-539-942","lens_id":["137-681-520-561-990","008-118-188-539-942","163-836-104-762-618"],"sequence":52,"category":[],"us_category":[],"cited_phase":"APP","rel_claims":[]}},{"npl":{"num":41,"text":"Meister, A., Reduction of alpha gamma-diketo and alpha-keto acids catalyzed by muscle preparations and by crystalline lactic dehydrogenase, The Journal of Biological Chemistry, 184:117-129 (1950).","npl_type":"a","external_id":["15421980","10.1016/s0021-9258(19)51130-9"],"record_lens_id":"099-567-555-090-10X","lens_id":["154-186-096-749-860","099-567-555-090-10X","181-668-787-932-69X"],"sequence":53,"category":[],"us_category":[],"cited_phase":"APP","rel_claims":[]}},{"npl":{"num":42,"text":"Metallo, C.M., et al., Reductive glutamine metabolism by IDH1 mediates lipogenesis under hypoxia, Nature, 481:380-384 (2012).","npl_type":"a","external_id":["pmc3710581","22101433","10.1038/nature10602"],"record_lens_id":"067-693-113-500-948","lens_id":["151-600-899-184-930","139-179-974-037-041","067-693-113-500-948"],"sequence":54,"category":[],"us_category":[],"cited_phase":"APP","rel_claims":[]}},{"npl":{"num":43,"text":"Metellus, P. et al., IDH mutation status impact on in vivo hypoxia biomarkers expression: new insights from a clinical, nuclear imaging and immunohistochemical study in 33 glioma patients, J. Neurooncol., 105(3):591-600 (2011).","npl_type":"a","external_id":["10.1007/s11060-011-0625-2","21643985"],"record_lens_id":"084-149-551-379-292","lens_id":["093-208-004-955-071","125-147-389-412-125","084-149-551-379-292"],"sequence":55,"category":[],"us_category":[],"cited_phase":"APP","rel_claims":[]}},{"npl":{"num":44,"text":"Millard, P., et al., IsoCor: correcting MS data in isotope labeling experiments, Bioinformatics, 28:1294-1296 (2012).","npl_type":"a","external_id":["22419781","10.1093/bioinformatics/bts127"],"record_lens_id":"010-545-628-084-127","lens_id":["028-698-360-515-23X","109-910-967-838-221","010-545-628-084-127"],"sequence":56,"category":[],"us_category":[],"cited_phase":"APP","rel_claims":[]}},{"npl":{"num":45,"text":"Moroni, I., et al., L-2-hydroxyglutaric aciduria and brain malignant tumors: a predisposing condition? Neurology, 62:1882-1884 (2004).","npl_type":"a","external_id":["15159502","10.1212/01.wnl.0000125335.21381.87"],"record_lens_id":"012-258-987-076-736","lens_id":["170-688-222-609-616","044-369-098-092-683","012-258-987-076-736"],"sequence":57,"category":[],"us_category":[],"cited_phase":"APP","rel_claims":[]}},{"npl":{"num":46,"text":"Nombela-Arrieta, C., et al., Quantitative imaging of haematopoietic stem and progenitor cell localization and hypoxic status in the bone marrow microenvironment, Nature Cell Biology, 15:533-543 (2013).","npl_type":"a","external_id":["pmc4156024","23624405","10.1038/ncb2730"],"record_lens_id":"004-782-371-138-602","lens_id":["127-337-159-438-143","019-712-001-778-152","004-782-371-138-602"],"sequence":58,"category":[],"us_category":[],"cited_phase":"APP","rel_claims":[]}},{"npl":{"num":47,"text":"Olsson, M.H.M., et al., PROPKA3: Consistent Treatment of Internal and Surface Residues in Empirical pK(a) Predictions, J Chem Theory Comput, 7:525-537 (2011).","npl_type":"a","external_id":["10.1021/ct100578z","26596171"],"record_lens_id":"030-491-312-361-321","lens_id":["064-617-851-857-697","059-230-075-626-695","030-491-312-361-321"],"sequence":59,"category":[],"us_category":[],"cited_phase":"APP","rel_claims":[]}},{"npl":{"num":48,"text":"Ozer, A., and Bruick, R.K., Non-heme dioxygenases: cellular sensors and regulators jelly rolled into one? Nature Chemical Biology, 3:144-153 (2007).","npl_type":"a","external_id":["10.1038/nchembio863","17301803"],"record_lens_id":"101-717-012-479-005","lens_id":["118-536-187-418-559","101-717-012-479-005","151-978-568-777-63X"],"sequence":60,"category":[],"us_category":[],"cited_phase":"APP","rel_claims":[]}},{"npl":{"num":49,"text":"Papandreou, I. et al., HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption, Cell Metab., 3(3):187-97 (2006).","npl_type":"a","external_id":["10.1016/j.cmet.2006.01.012","16517406"],"record_lens_id":"015-795-279-753-831","lens_id":["180-862-228-197-599","015-795-279-753-831","182-405-702-402-705"],"sequence":61,"category":[],"us_category":[],"cited_phase":"APP","rel_claims":[]}},{"npl":{"num":50,"text":"Parsons, D.W., et al., An integrated genomic analysis of human glioblastoma multiforme, Science, 321:1807-1812 (2008).","npl_type":"a","external_id":["10.1126/science.1164382","18772396","pmc2820389"],"record_lens_id":"001-568-098-749-368","lens_id":["069-841-882-909-291","140-680-492-275-850","001-568-098-749-368"],"sequence":62,"category":[],"us_category":[],"cited_phase":"APP","rel_claims":[]}},{"npl":{"num":51,"text":"Partial Supplementary European Search Report for 12850119.4, 5 pages (dated Apr. 21, 2015).","npl_type":"a","external_id":[],"lens_id":[],"sequence":63,"category":[],"us_category":[],"cited_phase":"APP","rel_claims":[]}},{"npl":{"num":52,"text":"Patel, J.P., et al., Prognostic relevance of integrated genetic profiling in acute myeloid leukemia, The New England Journal of Medicine, 366:1079-1089 (2012).","npl_type":"a","external_id":["10.1056/nejmoa1112304","pmc3545649","22417203"],"record_lens_id":"172-472-461-501-864","lens_id":["189-103-902-139-594","191-375-016-526-654","172-472-461-501-864"],"sequence":64,"category":[],"us_category":[],"cited_phase":"APP","rel_claims":[]}},{"npl":{"num":53,"text":"Patiar, S. and Harris, A.L., Role of hypoxia-inducible factor-1 alpha as a cancer therapy target, Endocr. Relat. Cancer, 13 Suppl 1:S61-75 (2006).","npl_type":"a","external_id":["17259560","10.1677/erc.1.01290"],"record_lens_id":"005-380-865-717-721","lens_id":["059-323-718-735-178","005-380-865-717-721","070-195-352-238-402"],"sequence":65,"category":[],"us_category":[],"cited_phase":"APP","rel_claims":[]}},{"npl":{"num":54,"text":"Patterson, A.L., et al., Absolute Configuration of Naturally Occurring Isocitric Acid, J Am Chem Soc, 84:309-310 (1962).","npl_type":"a","external_id":["10.1021/ja00861a039"],"record_lens_id":"066-957-849-455-510","lens_id":["169-866-230-253-043","066-957-849-455-510"],"sequence":66,"category":[],"us_category":[],"cited_phase":"APP","rel_claims":[]}},{"npl":{"num":55,"text":"Rakheja, D. et al., Papillary thyroid carcinoma shows elevated levels of 2-hydroxyglutarate, Tumor Biology, 32:325-333 (2011).","npl_type":"a","external_id":["21080253","10.1007/s13277-010-0125-6"],"record_lens_id":"049-444-539-560-526","lens_id":["144-159-649-181-608","111-528-117-421-264","049-444-539-560-526"],"sequence":67,"category":[],"us_category":[],"cited_phase":"APP","rel_claims":[]}},{"npl":{"num":56,"text":"Read, J.A., et al., Structural basis for altered activity of M- and H-isozyme forms of human lactate dehydrogenase, Proteins, 43:175-185 (2001).","npl_type":"a","external_id":["10.1002/1097-0134(20010501)43:2<175::aid-prot1029>3.0.co;2-","11276087","10.1002/1097-0134(20010501)43:2<175::aid-prot1029>3.0.co;2-#"],"record_lens_id":"081-813-863-353-490","lens_id":["124-027-292-537-869","081-813-863-353-490","157-637-909-787-776","113-108-753-823-67X"],"sequence":68,"category":[],"us_category":[],"cited_phase":"APP","rel_claims":[]}},{"npl":{"num":57,"text":"Rohle, D., et al., An inhibitor of mutant IDH1 delays growth and promotes differentiation of glioma cells, Science, 340:626-630 (2013).","npl_type":"a","external_id":["pmc3985613","10.1126/science.1236062","23558169"],"record_lens_id":"069-612-077-896-054","lens_id":["121-595-801-299-819","077-580-294-500-032","069-612-077-896-054"],"sequence":69,"category":[],"us_category":[],"cited_phase":"APP","rel_claims":[]}},{"npl":{"num":58,"text":"Rzem, R., et al., A gene encoding a putative FAD-dependent L-2-hydroxyglutarate dehydrogenase is mutated in L-2-hydroxyglutaric aciduria, Proceedings of the National Academy of Sciences of the United States of America, 101:16849-16854 (2004).","npl_type":"a","external_id":["15548604","pmc534725","10.1073/pnas.0404840101"],"record_lens_id":"032-168-853-293-109","lens_id":["139-546-431-409-381","032-168-853-293-109","087-176-728-055-828"],"sequence":70,"category":[],"us_category":[],"cited_phase":"APP","rel_claims":[]}},{"npl":{"num":59,"text":"Rzem, R., et al., L-2-hydroxyglutaric aciduria, a defect of metabolite repair, Journal of Inherited Metabolic Disease, 30:681-689 (2007).","npl_type":"a","external_id":["17603759","10.1007/s10545-007-0487-0"],"record_lens_id":"020-607-851-316-190","lens_id":["196-165-276-501-898","020-607-851-316-190","181-573-361-813-405"],"sequence":71,"category":[],"us_category":[],"cited_phase":"APP","rel_claims":[]}},{"npl":{"num":60,"text":"Sasaki, M., et al., IDH1(R132H) mutation increases murine haematopoietic progenitors and alters epigenetics, Nature, 488:656-659 (2012).","npl_type":"a","external_id":["10.1038/nature11323","pmc4005896","22763442"],"record_lens_id":"064-167-429-189-296","lens_id":["102-108-341-673-530","100-554-181-911-233","064-167-429-189-296"],"sequence":72,"category":[],"us_category":[],"cited_phase":"APP","rel_claims":[]}},{"npl":{"num":61,"text":"Schatz, L., and Segal, H.L., Reduction of alpha-ketoglutarate by homogeneous lactic dehydrogenase X of testicular tissue, The Journal of biological chemistry, 244:4393-4397 (1969).","npl_type":"a","external_id":["4308858","10.1016/s0021-9258(18)94331-0"],"record_lens_id":"023-842-873-254-305","lens_id":["091-031-021-437-643","023-842-873-254-305","118-019-828-495-621"],"sequence":73,"category":[],"us_category":[],"cited_phase":"APP","rel_claims":[]}},{"npl":{"num":62,"text":"Semenza, G.L., HIF-1 mediates metabolic responses to intratumoral hypoxia and oncogenic mutations, The Journal of Clinical Investigation, 123: 3664-3671 (2013).","npl_type":"a","external_id":["10.1172/jci67230","pmc3754249","23999440"],"record_lens_id":"034-340-556-070-19X","lens_id":["114-062-058-514-504","034-340-556-070-19X","083-053-651-638-80X"],"sequence":74,"category":[],"us_category":[],"cited_phase":"APP","rel_claims":[]}},{"npl":{"num":63,"text":"Shim, E.H., et al., L-2-Hydroxyglutarate: An Epigenetic Modifier and Putative Oncometabolite in Renal Cancer, Cancer Discovery, 4:1290-1298 (2014).","npl_type":"a","external_id":["pmc4286872","10.1158/2159-8290.cd-13-0696","25182153"],"record_lens_id":"002-245-892-156-48X","lens_id":["170-634-176-157-255","088-435-337-029-809","002-245-892-156-48X"],"sequence":75,"category":[],"us_category":[],"cited_phase":"APP","rel_claims":[]}},{"npl":{"num":64,"text":"Simon, M.C., and Keith, B., The role of oxygen availability in embryonic development and stem cell function, Nature Reviews Molecular Cell Biology, 9:285-296 (2008).","npl_type":"a","external_id":["pmc2876333","18285802","10.1038/nrm2354"],"record_lens_id":"052-550-627-791-962","lens_id":["168-799-363-350-783","198-480-784-905-701","052-550-627-791-962"],"sequence":76,"category":[],"us_category":[],"cited_phase":"APP","rel_claims":[]}},{"npl":{"num":65,"text":"Sondergaard, C.R., et al., Improved Treatment of Ligands and Coupling Effects in Empirical Calculation and Rationalization of pK(a) Values, J Chem Theory Comput, 7:2284-2295 (2011).","npl_type":"a","external_id":["26606496","10.1021/ct200133y"],"record_lens_id":"037-314-345-188-489","lens_id":["175-898-034-354-713","192-251-842-859-858","037-314-345-188-489"],"sequence":77,"category":[],"us_category":[],"cited_phase":"APP","rel_claims":[]}},{"npl":{"num":66,"text":"Spencer, J.A., et al., Direct measurement of local oxygen concentration in the bone marrow of live animals, Nature, 508:269-273 (2014).","npl_type":"a","external_id":["10.1038/nature13034","24590072","pmc3984353"],"record_lens_id":"031-996-653-696-509","lens_id":["185-479-967-973-862","132-445-928-516-038","031-996-653-696-509"],"sequence":78,"category":[],"us_category":[],"cited_phase":"APP","rel_claims":[]}},{"npl":{"num":67,"text":"Sprecher, M., et al, Stereochemical Course of the Isocitrate Lyase Reaction, The Journal of Biological Chemistry, 239:4268-4271 (1964).","npl_type":"a","external_id":["14247681","10.1016/s0021-9258(18)91168-3"],"record_lens_id":"122-294-247-935-351","lens_id":["127-948-723-630-324","122-294-247-935-351","128-025-801-458-955"],"sequence":79,"category":[],"us_category":[],"cited_phase":"APP","rel_claims":[]}},{"npl":{"num":68,"text":"Struys, E.A. et al., Measurement of urinary D- and L-2-hydroxyglutarate enantiomers by stable-isotope-dilution liquid chromatography-tandem mass spectrometry after derivatization with diacetyl-L-tartaric anhydride, Clin. Chem., 50(8):1391-5 (2004).","npl_type":"a","external_id":["10.1373/clinchem.2004.033399","15166110"],"record_lens_id":"069-834-263-365-576","lens_id":["126-220-294-901-502","069-834-263-365-576","114-660-552-630-674"],"sequence":80,"category":[],"us_category":[],"cited_phase":"APP","rel_claims":[]}},{"npl":{"num":69,"text":"Struys, E.A., et al., Mutations in the D-2-hydroxyglutarate dehydrogenase gene cause D-2-hydroxyglutaric aciduria, American Journal of Human Genetics, 76:358-360 (2005).","npl_type":"a","external_id":["10.1086/427890","pmc1196381","15609246"],"record_lens_id":"016-005-267-511-699","lens_id":["036-621-842-687-370","016-005-267-511-699","138-665-080-397-440"],"sequence":81,"category":[],"us_category":[],"cited_phase":"APP","rel_claims":[]}},{"npl":{"num":70,"text":"Struys, E.A., et al., Novel insights into L-2-hydroxyglutaric aciduria: mass isotopomer studies reveal 2-oxoglutaric acid as the metabolic precursor of L-2-hydroxyglutaric acid, Journal of Inherited Metabolic Disease, 30:690-693 (2007).","npl_type":"a","external_id":["10.1007/s10545-007-0697-5","17876720"],"record_lens_id":"010-411-761-244-720","lens_id":["086-460-304-935-663","010-411-761-244-720","117-707-107-260-956"],"sequence":82,"category":[],"us_category":[],"cited_phase":"APP","rel_claims":[]}},{"npl":{"num":71,"text":"Suda, T., et al., Metabolic regulation of hematopoietic stem cells in the hypoxic niche, Cell Stem Cell, 9:298-310 (2011).","npl_type":"a","external_id":["10.1016/j.stem.2011.09.010","21982230"],"record_lens_id":"024-462-035-250-964","lens_id":["170-665-762-999-131","123-846-538-518-098","024-462-035-250-964"],"sequence":83,"category":[],"us_category":[],"cited_phase":"APP","rel_claims":[]}},{"npl":{"num":72,"text":"Tausendschon, M., et al., Hypoxia causes epigenetic gene regulation in macrophages by attenuating Jumonji histone demethylase activity, Cytokine, 53:256-262 (2011).","npl_type":"a","external_id":["10.1016/j.cyto.2010.11.002","21131212"],"record_lens_id":"029-170-431-557-789","lens_id":["169-035-850-399-804","174-818-087-099-956","029-170-431-557-789"],"sequence":84,"category":[],"us_category":[],"cited_phase":"APP","rel_claims":[]}},{"npl":{"num":73,"text":"Terunuma, A., et al., MYC-driven accumulation of 2-hydroxyglutarate is associated with breast cancer prognosis, The Journal of Clinical Investigation, 124:398-412 (2014).","npl_type":"a","external_id":["10.1172/jci71180","pmc3871244","24316975"],"record_lens_id":"016-810-652-581-417","lens_id":["040-696-207-667-259","112-819-987-501-184","016-810-652-581-417"],"sequence":85,"category":[],"us_category":[],"cited_phase":"APP","rel_claims":[]}},{"npl":{"num":74,"text":"Vander Heiden, M.G., et al., Understanding the Warburg effect: the metabolic requirements of cell proliferation, Science, 324:1029-1033 (2009).","npl_type":"a","external_id":["19460998","10.1126/science.1160809","pmc2849637"],"record_lens_id":"010-342-417-481-069","lens_id":["069-811-513-886-55X","066-251-397-147-765","010-342-417-481-069"],"sequence":86,"category":[],"us_category":[],"cited_phase":"APP","rel_claims":[]}},{"npl":{"num":75,"text":"Venneti, S., et al., Evaluation of histone 3 lysine 27 trimethylation (H3K27me3) and enhancer of Zest 2 (EZH2) in pediatric glial and glioneuronal tumors shows decreased H3K27me3 in H3F3A K27M mutant glioblastomas, Brain Pathol, 23:558-564 (2013).","npl_type":"a","external_id":["pmc3701028","10.1111/bpa.12042","23414300"],"record_lens_id":"059-360-935-433-750","lens_id":["182-522-255-635-12X","153-544-136-728-441","059-360-935-433-750"],"sequence":87,"category":[],"us_category":[],"cited_phase":"APP","rel_claims":[]}},{"npl":{"num":76,"text":"Venneti, S., et al., Histone 3 lysine 9 trimethylation is differentially associated with isocitrate dehydrogenase mutations in oligodendrogliomas and high-grade astrocytomas, Journal of Neuropathology and Experimental Neurology, 72:298-306 (2013).","npl_type":"a","external_id":["23481705","pmc3615673","10.1097/nen.0b013e3182898113"],"record_lens_id":"074-761-464-576-202","lens_id":["083-447-099-965-154","083-209-936-074-225","074-761-464-576-202"],"sequence":88,"category":[],"us_category":[],"cited_phase":"APP","rel_claims":[]}},{"npl":{"num":77,"text":"Wang, F., et al., Targeted inhibition of mutant IDH2 in leukemia cells induces cellular differentiation, Science, 340:622-626 (2013).","npl_type":"a","external_id":["23558173","10.1126/science.1234769"],"record_lens_id":"019-915-410-480-744","lens_id":["084-740-487-712-019","069-241-712-272-735","019-915-410-480-744"],"sequence":89,"category":[],"us_category":[],"cited_phase":"APP","rel_claims":[]}},{"npl":{"num":78,"text":"Wang, Y.H., et al., Cell-state-specific metabolic dependency in hematopoiesis and leukemogenesis, Cell, 158:1309-1323 (2014).","npl_type":"a","external_id":["pmc4197056","10.1016/j.cell.2014.07.048","25215489"],"record_lens_id":"000-241-064-028-801","lens_id":["113-093-515-042-676","196-272-569-400-197","000-241-064-028-801"],"sequence":90,"category":[],"us_category":[],"cited_phase":"APP","rel_claims":[]}},{"npl":{"num":79,"text":"Ward, P.S. et al., Identification of additional IDH mutations associated with oncometabolite R(−)-2-hydroxyglutarate production, Oncogene, 31(19):2491-8 (2012).","npl_type":"a","external_id":["21996744","10.1038/onc.2011.416","pmc3271133"],"record_lens_id":"003-523-335-536-213","lens_id":["084-311-609-266-42X","053-316-156-787-908","003-523-335-536-213"],"sequence":91,"category":[],"us_category":[],"cited_phase":"APP","rel_claims":[]}},{"npl":{"num":80,"text":"Ward, P.S. et al., The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting alpha-ketoglutarate to 2-hydroxyglutarate, Cancer Cell, 17(3):225-34 (2010).","npl_type":"a","external_id":["pmc2849316","10.7554/elife.12626.003","10.3410/f.720539740.793505017","20171147","10.1016/j.ccr.2010.01.020"],"record_lens_id":"077-226-361-130-237","lens_id":["124-083-570-272-757","127-685-431-922-446","084-033-187-736-42X","077-226-361-130-237","139-499-187-313-177","149-597-660-800-416","012-160-735-984-150"],"sequence":92,"category":[],"us_category":[],"cited_phase":"APP","rel_claims":[]}},{"npl":{"num":81,"text":"Ward, P.S., and Thompson, C.B., Metabolic reprogramming: a cancer hallmark even warburg did not anticipate, Cancer Cell, 21:297-308 (2012).","npl_type":"a","external_id":["22439925","pmc3311998","10.1016/j.ccr.2012.02.014"],"record_lens_id":"119-931-926-781-244","lens_id":["192-200-066-060-17X","162-632-609-490-872","119-931-926-781-244"],"sequence":93,"category":[],"us_category":[],"cited_phase":"APP","rel_claims":[]}},{"npl":{"num":82,"text":"Wise, D.R. et al., Hypoxia promotes isocitrate dehydrogenase-dependent carboxylation of α-ketoglutarate to citrate to support cell growth and viability, Proc. Natl. Acad. Sci. U S A., 108(49):19611-6 (2011).","npl_type":"a","external_id":[],"lens_id":[],"sequence":94,"category":[],"us_category":[],"cited_phase":"APP","rel_claims":[]}},{"npl":{"num":83,"text":"Wise, D.R. et al., Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction, Proc. Natl. Acad. Sci. USA, 105(48):18782-7 (2008).","npl_type":"a","external_id":["10.1073/pnas.0810199105","pmc2596212","19033189"],"record_lens_id":"003-282-838-950-93X","lens_id":["187-909-737-558-399","100-853-190-777-777","003-282-838-950-93X"],"sequence":95,"category":[],"us_category":[],"cited_phase":"APP","rel_claims":[]}},{"npl":{"num":84,"text":"Wise, D.R., and Thompson, C.B., Glutamine addiction: a new therapeutic target in cancer, Trends in Biochemical Sciences, 35:427-433 (2010).","npl_type":"a","external_id":["10.1016/j.tibs.2010.05.003","pmc2917518","20570523"],"record_lens_id":"062-254-189-823-798","lens_id":["198-154-427-975-425","176-285-733-374-46X","062-254-189-823-798"],"sequence":96,"category":[],"us_category":[],"cited_phase":"APP","rel_claims":[]}},{"npl":{"num":85,"text":"Written Opinion for PCT/US2012/065731, 7 pages (dated Feb. 8, 2013).","npl_type":"a","external_id":[],"lens_id":[],"sequence":97,"category":[],"us_category":[],"cited_phase":"APP","rel_claims":[]}},{"npl":{"num":86,"text":"Written Opinion for PCT/US2015/23038, 11 pages (dated Aug. 19, 2015).","npl_type":"a","external_id":[],"lens_id":[],"sequence":98,"category":[],"us_category":[],"cited_phase":"APP","rel_claims":[]}},{"npl":{"num":87,"text":"Xie, H., et al., Targeting lactate dehydrogenase—a inhibits tumorigenesis and tumor progression in mouse models of lung cancer and impacts tumor-initiating cells, Cell Metabolism, 19:795-809 (2014).","npl_type":"a","external_id":["pmc4096909","24726384","10.1016/j.cmet.2014.03.003"],"record_lens_id":"077-587-054-407-674","lens_id":["133-606-835-093-225","145-974-278-361-200","077-587-054-407-674"],"sequence":99,"category":[],"us_category":[],"cited_phase":"APP","rel_claims":[]}},{"npl":{"num":88,"text":"Xu, W., et al., Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of alpha-ketoglutarate-dependent dioxygenases, Cancer Cell, 19:17-30 (2011).","npl_type":"a","external_id":["21251613","pmc3229304","10.1016/j.ccr.2010.12.014"],"record_lens_id":"090-282-018-444-682","lens_id":["131-440-581-692-200","181-360-875-913-957","090-282-018-444-682"],"sequence":100,"category":[],"us_category":[],"cited_phase":"APP","rel_claims":[]}},{"npl":{"num":89,"text":"Yan, H., et al., IDH1 and IDH2 mutations in gliomas, The New England Journal of Medicine, 360:765-773 (2009).","npl_type":"a","external_id":["19228619","10.1056/nejmoa0808710","pmc2820383"],"record_lens_id":"040-988-224-915-933","lens_id":["090-519-921-614-628","162-342-361-408-832","040-988-224-915-933"],"sequence":101,"category":[],"us_category":[],"cited_phase":"APP","rel_claims":[]}},{"npl":{"num":90,"text":"Zhdanov, A.V., et al., Differential contribution of certain metabolic substrates and cellular oxygen in HIF signalling, Experimental Cell Research (2014).","npl_type":"a","external_id":["25447307","10.1016/j.yexcr.2014.10.005"],"record_lens_id":"027-408-638-285-762","lens_id":["078-296-810-511-271","114-354-361-658-628","027-408-638-285-762"],"sequence":102,"category":[],"us_category":[],"cited_phase":"APP","rel_claims":[]}},{"npl":{"num":91,"text":"Bristow, R. G. and Hill, R. P., Hypoxia, DNA repair and genetic instability, Nature Reviews, 8: 180-192 (2008).","npl_type":"a","external_id":["18273037","10.1038/nrc2344"],"record_lens_id":"013-678-336-599-274","lens_id":["061-913-788-984-841","029-097-122-344-773","013-678-336-599-274"],"sequence":103,"category":[],"us_category":[],"cited_phase":"APP","rel_claims":[]}},{"npl":{"num":92,"text":"Kaur, B. et al, Hypoxia and the hypoxia-inducible-factor pathway in glioma growth and angiogenesis, Neuro. Oncol., 7(2): 134-53 (2005).","npl_type":"a","external_id":["15831232","10.1215/s1152851704001115","pmc1871894"],"record_lens_id":"085-130-198-564-580","lens_id":["121-835-834-711-670","085-130-198-564-580","129-331-529-272-263"],"sequence":104,"category":[],"us_category":[],"cited_phase":"APP","rel_claims":[]}},{"npl":{"num":93,"text":"Kohshi, K. et al, Radiotherapy after hyperbaric oxygenation for malignant gliomas: a pilot study, J. Cancer Res. Clin. Oncol., 122: 676-678 (1996).","npl_type":"a","external_id":["10.1007/bf01209031","8898978"],"record_lens_id":"063-035-414-581-34X","lens_id":["199-352-584-396-391","063-035-414-581-34X","111-818-544-569-795"],"sequence":105,"category":[],"us_category":[],"cited_phase":"APP","rel_claims":[]}},{"npl":{"num":94,"text":"Schaap, F. et al., Mutations in the Isocitrate Dehydrogenase Genes IDH1 and IDH2 in Tumors, Adv Anat. Pathol., 20:32-38 (2013).","npl_type":"a","external_id":["23232569","10.1097/pap.0b013e31827b654d"],"record_lens_id":"007-180-920-924-86X","lens_id":["069-892-250-496-759","086-418-503-493-707","007-180-920-924-86X"],"sequence":106,"category":[],"us_category":[],"cited_phase":"APP","rel_claims":[]}},{"npl":{"num":95,"text":"Bethesda Hyperbaric Oxygen Therapy, Epilepsy—Bethesda Hyperbaric Oxygen Therapy, 3 pages, (2009),
contacting the cancer cell with a vector comprising a nucleic acid molecule encoding L-2-hydroxyglutarate dehydrogenase such that L-2-hydroxyglutarate dehydrogenase expression is elevated."],"number":1,"annotation":false,"claim":true,"title":false},{"lines":["The method of claim 1, wherein the cell is contacted with a sufficient amount of the vector encoding L-2-hydroxyglutarate dehydrogenase to promote differentiation."],"number":2,"annotation":false,"claim":true,"title":false},{"lines":["The method of claim 1, wherein the cell is in a subject suffering from cancer, wherein contacting the cell comprises administering to the subject the vector encoding L-2-hydroxyglutarate dehydrogenase."],"number":3,"annotation":false,"claim":true,"title":false},{"lines":["The method of claim 3, wherein the subject has wild type isocitrate dehydrogenase 1 or 2 (IDH1/2)."],"number":4,"annotation":false,"claim":true,"title":false},{"lines":["The method of claim 1, wherein the cell is contacted with an amount of the vector expressing L-2-hydroxyglutarate dehydrogenase sufficient to inhibit histone methylation."],"number":5,"annotation":false,"claim":true,"title":false},{"lines":["The method of claim 1, wherein the cell is a tumor cell and the amount of the vector encoding L-2-hydroxyglutarate dehydrogenase is therapeutically effective to inhibit tumor angiogenesis."],"number":6,"annotation":false,"claim":true,"title":false},{"lines":["The method of claim 5, wherein the inhibited histone methylation is H3K9me3."],"number":7,"annotation":false,"claim":true,"title":false},{"lines":["The method of claim 1, wherein the expression level is elevated compared to an empty vector control."],"number":8,"annotation":false,"claim":true,"title":false},{"lines":["The method of claim 1, wherein the cancer cell is a glioblastoma cancer cell."],"number":9,"annotation":false,"claim":true,"title":false},{"lines":["The method of claim 1, wherein the expression level is elevated to a level above endogenous levels of a non-cancer cell."],"number":10,"annotation":false,"claim":true,"title":false}]}},"filters":{"npl":[],"notNpl":[],"applicant":[],"notApplicant":[],"inventor":[],"notInventor":[],"owner":[],"notOwner":[],"tags":[],"dates":[],"types":[],"notTypes":[],"j":[],"notJ":[],"fj":[],"notFj":[],"classIpcr":[],"notClassIpcr":[],"classNat":[],"notClassNat":[],"classCpc":[],"notClassCpc":[],"so":[],"notSo":[],"sat":[]},"sequenceFilters":{"s":"SEQIDNO","d":"ASCENDING","p":0,"n":10,"sp":[],"si":[],"len":[],"t":[],"loc":[]}}